Additionally, Lu et al. [99] demonstrated that hypermethylation of RASSF1A, COX2, and APC genes detected in ctDNA can identify those HCC patients with negative AFP levels and is associated with greater susceptibility to tumor recurrence and poor survival prognosis. The gene discussed is RASSF1; the disease is hepatocellular carcinoma.